Viewing stories from September, 2021
US patent issued for DEP® cabazitaxel nanoparticle (ASX Announcement)
Starpharma today announced that the US Patent and Trademark Office has granted a new patent in relation to DEP® cabazitaxel.
Starpharma today announced that the US Patent and Trademark Office has granted a new patent in relation to DEP® cabazitaxel.
You have selected a link that will redirect you to a site maintained by a third party who is solely responsible for its contents.
Starpharma provides this link as a service to website visitors. Starpharma is not responsible for the privacy policy of any third party websites. Read the privacy policy of every website you visit.
To proceed, click ‘continue’.